BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 13, 2010
 |  BC Week In Review  |  Company News  |  Other News

Alnylam, Silence Therapeutics, BASF, Merck, Pfizer chemistry news

Alnylam said the Opposition Division of the European Patent Office (EPO) upheld European Patent No. EP1407044, part of the company's Tuschl II estate. The patent covers compositions, methods and uses of...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >